Peripheral Venous Pressure Variation, Pulse Pressure Variation and Pleth Variability Index for Fluid Responsiveness

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age19-80
SponsorSeoul National University Bundang Hospital

About this trial

Pulse pressure variation (PPV) and pleth variability index (PVI) are widely used in clinical practice as indicators of the responsiveness to fluid therapy in patients receiving mechanical ventilation. PPV, which measures changes in arterial pressure, requires arterial puncture, which is invasive, and PVI, which detects subtle changes in oxygen saturation, requires an expensive, commercial monitoring equipment. In this study, we aimed to measure peripheral venous pressure variation using less invasive waveform variation in peripheral veins and to determine whether this indicator can be clinically used to predict the responsiveness to fluid therapy. In addition, the investigators aimed to confirm the superiority of the indicators by comparing them with the responsiveness to fluid therapy of the PPV and PVI.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients voluntarily agreed and signed the written informed consent form before participating in the study

Adults aged 19 years or older

American Society of Anesthesiologists physical class (ASA) 1-3

Patients scheduled for elective hepatectomy under general anesthesia

Disqualifiers

Patients with abnormal findings on electrocardiogram before surgery

Patients who cannot undergo peripheral venous puncture

Trial population

Patients scheduled for elective hepatectomy under general anesthesia

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • peripheral waveform collection

    Other intervention

    The peripheral venous pressure is collected by connecting a pressure transducer that is currently in use to the central venous line. In addition, pulse pressure variation and stroke volume variation that can be obtained from the arterial catheter. In addition, the pleth variability index is collected through the oxygen saturation monitoring. This extracts the medical records and bio-signal information of the subjects registered through the previously approved 'Establishment of a Bio-signal and Clinical Information Registry for the Development of Patient Monitoring Algorithms' (B-2202-738-401).

Treatment groups

150 Participants
are divided into 1 treatment group
Group A: peripheral waveform collection group1 intervention

Trial outcomes

Primary outcomes

1

Fluid responsiveness

Cardiac output increases by more than 15% after 250 mL crystalloid injection during a fluid challenge

Time frame
intraoperative period

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: